Lexeo Therapeutics Common Stock Statistics Share Statistics Lexeo Therapeutics Common Stock has 33.2M
shares outstanding. The number of shares has increased by 0.41%
in one year.
Shares Outstanding 33.2M Shares Change (YoY) 0.41% Shares Change (QoQ) 0% Owned by Institutions (%) 82.47% Shares Floating 22.9M Failed to Deliver (FTD) Shares 614 FTD / Avg. Volume 0.1%
Short Selling Information The latest short interest is 5.18M, so 15.6% of the outstanding
shares have been sold short.
Short Interest 5.18M Short % of Shares Out 15.6% Short % of Float 18.19% Short Ratio (days to cover) 12.03
Valuation Ratios The PE ratio is -2.13 and the forward
PE ratio is -2.33.
Lexeo Therapeutics Common Stock's PEG ratio is
-0.09.
PE Ratio -2.13 Forward PE -2.33 PS Ratio 0 Forward PS n/a PB Ratio 1.79 P/FCF Ratio -2.56 PEG Ratio -0.09
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lexeo Therapeutics Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.52,
with a Debt / Equity ratio of 0.08.
Current Ratio 5.52 Quick Ratio 5.52 Debt / Equity 0.08 Debt / EBITDA -0.1 Debt / FCF -0.12 Interest Coverage -927.77
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.31M Employee Count 75 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -62.94% in the
last 52 weeks. The beta is 1.36, so Lexeo Therapeutics Common Stock's
price volatility has been higher than the market average.
Beta 1.36 52-Week Price Change -62.94% 50-Day Moving Average 4.11 200-Day Moving Average 4.86 Relative Strength Index (RSI) 54.78 Average Volume (20 Days) 602,790
Income Statement
Revenue n/a Gross Profit n/a Operating Income -105.77M Net Income -98.33M EBITDA -96.22M EBIT -98.47M Earnings Per Share (EPS) -3.09
Full Income Statement Balance Sheet The company has 35.01M in cash and 9.92M in
debt, giving a net cash position of 25.09M.
Cash & Cash Equivalents 35.01M Total Debt 9.92M Net Cash 25.09M Retained Earnings -280.17M Total Assets 125.69M Working Capital 74.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -81.15M
and capital expenditures -481K, giving a free cash flow of -81.63M.
Operating Cash Flow -81.15M Capital Expenditures -481K Free Cash Flow -81.63M FCF Per Share -2.57
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
